GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve (IST:ANGEN) » Definitions » Return-on-Tangible-Equity

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Return-on-Tangible-Equity : 1.97% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's annualized net income for the quarter that ended in Sep. 2023 was ₺14.6 Mil. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's average shareholder tangible equity for the quarter that ended in Sep. 2023 was ₺740.5 Mil. Therefore, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2023 was 1.97%.

The historical rank and industry rank for Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Return-on-Tangible-Equity or its related term are showing as below:

IST:ANGEN' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 16.19   Med: 83.39   Max: 193.4
Current: 16.19

During the past 5 years, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's highest Return-on-Tangible-Equity was 193.40%. The lowest was 16.19%. And the median was 83.39%.

IST:ANGEN's Return-on-Tangible-Equity is ranked better than
80.39% of 760 companies
in the Medical Devices & Instruments industry
Industry Median: 1.32 vs IST:ANGEN: 16.19

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Return-on-Tangible-Equity Historical Data

The historical data trend for Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Return-on-Tangible-Equity Chart

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Return-on-Tangible-Equity
21.44 116.49 193.40 83.39 43.56

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Quarterly Data
Dec18 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.90 13.05 6.11 43.09 1.97

Competitive Comparison of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Return-on-Tangible-Equity

For the Medical Devices subindustry, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Return-on-Tangible-Equity falls into.



Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Return-on-Tangible-Equity Calculation

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=330.39/( (743.888+773.008 )/ 2 )
=330.39/758.448
=43.56 %

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=14.552/( (741.316+739.657)/ 2 )
=14.552/740.4865
=1.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve  (IST:ANGEN) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Business Description

Traded in Other Exchanges
N/A
Address
Egitim Mah. Kasap Ismail, Sk. No:10 D:23, Kadikoy, Istanbul, TUR, 34722
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve Ticaret AS is an international biotechnology company. It is engaged in designing, developing, and manufacturing Real-Time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments. It also manufactures NA Extraction kits, Microbiology kits, Genetic Disorders kits, Panel kits, Sequencing kits, Food Testing kits.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Headlines

No Headlines